Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 47 (11) , 733-742
Abstract
Background and objectives:Long-term diabetes mellitus may affect the absorption, distribution and metabolism of immunosuppressive agents used after organ transplantation. The aims of this study were...Keywords
This publication has 42 references indexed in Scilit:
- Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primatesToxicology, 2005
- Type 1 Diabetic Mice Are Protected from Acetaminophen HepatotoxicityToxicological Sciences, 2003
- Two-Hour Cyclosporine Concentration Determination: An Appropriate Tool to Monitor Neoral Therapy?Therapeutic Drug Monitoring, 2002
- Distribution of Cyclosporin in Organ Transplant RecipientsClinical Pharmacokinetics, 2002
- CyclosporinDrugs, 2001
- Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipientsBritish Journal of Clinical Pharmacology, 1997
- The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in HumansClinical Pharmacokinetics, 1991
- Disease-Induced Variations in Plasma Protein LevelsClinical Pharmacokinetics, 1990
- Protein Binding and Drug ClearanceClinical Pharmacokinetics, 1984
- Rationale for Monitoring Free Drug LevelsClinical Pharmacokinetics, 1984